Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2005; 11(43): 6792-6799
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6792
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6792
Table 1 Patients’ clinical characteristics
| Age (yr) | 63 ± 8 | (48 - 74) |
| Sex ratio, M/F | 30/13 | |
| Etiology of cirrhosis, HBV/HCV/unknown | 5/32/6 | |
| Previous history of overt hepatic encephalopathy, | ||
| None/Chronic | Apr-39 | |
| Child-Pugh score | 8.0 ± 2.2 | (5 -13) |
| Laboratory examinations | ||
| Platelet (104µL) | 7.5 ± 5.1 | (8 - 31.4) |
| Albumin (g/dL) | 2.9 ± 0.5 | (1.9 - 3.9) |
| Total bilirubin (mg/dL) | 2.0 ± 2.3 | (0.5 - 13.8) |
| Cholinesterase (∆pH) | 0.36 ± 0.19 | (0.11 - 0.97) |
| Plasma ammonia (µmol/L) | 38 ± 23 | (4 - 104) |
| Prothrombin time (%) | 69.1 ± 12.8 | (31.3 - 93.5) |
| BCAA to tyrosine ratio | 3.3 ± 1.3 | (1.32 - 6.95) |
| Neuropsychological test | ||
| Trail making test (s) | 54 ± 26 | (28 - 160) |
| Digit symbol test (gross point) | 35 ± 10 | (12 - 54) |
- Citation: Yamamoto M, Iwasa M, Matsumura K, Nakagawa Y, Fujita N, Kobayashi Y, Kaito M, Takeda K, Adachi Y. Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol 2005; 11(43): 6792-6799
- URL: https://www.wjgnet.com/1007-9327/full/v11/i43/6792.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i43.6792